8h00
Registration and welcome coffee
8h45
Welcome Address - Einstein Auditorium
9h00
OPENING KEYNOTE LECTURES - Einstein Auditorium
Christian Klein
Distinguished Scientist, is Department Head Cancer Immunotherapy Discovery 3, Head Oncology Programs & Site Head Roche Innovation Center Zurich
Roche pRED, Switzerland
Elisa Fontana
MD, PhD, Hospital Medical Director
The Sarah Cannon Research Institute in London, UK
10h00
Coffee Break at Exhibition Hall
10h30
Paving the way for the next-generation of Antibodies & New Modalities - Einstein Auditorium
Session I
John McCafferty
CEO
Maxion Therapeutics, UK
Paula Videira
Co-founder and CTO
CellmAbs
Associate Professor and Group Leader
UCIBIO, NOVA School of Science and Technology, NOVA University Lisbon, Portugal
Peter Molloy
Senior Fellow, Protein Engineering
Immunocore Ltd, UK
Antibody-based Cancer Therapies : latest developments - Barthez Auditorium
Alain Beck
Senior Director, Biologics CMC & developability
Pierre Fabre, France
Aiphi Andrée Nguyen
CEO
Skymab Biotherapeutics, France
Peter Lowe
Director Antibody Engineering
Merus, Netherlands
12h20
Lunch at Exhibition Hall
14h00
Paving the way for the next-generation of Antibodies & New Modalities - Einstein Auditorium
Session II
Caroline Barelle
CEO & founder
Elasmogen, UK
Stefan Zielonka
Global Head of Antibody Discovery & Protein Engineering
Merck Healthcare KGaA
Professor of Biomolecular Immunotherapy
Technical University of Darmstadt, Germany
Simone Oostindie
Director Research & Discovery
GYES, Netherlands
Discovery and Development on Non-IgG based antibodies treatments - Barthez Auditorium
Elizabeth Hardaker
VP of Biology
Epsilogen, UK
Mitchell Evers
Antibody Scientist
Utrecht University, Netherlands
Hicham Zegzouti
Senior Research Scientist - Group Leader
Promega, USA
16h00
Pitch Session : Innovative Approaches and New trend Technologies - Einstein Auditorium
Call for abstracts until April 12th, 2024
17h00
Round table - Enhancing Investment Understanding - Einstein Auditorium
17h50
Investor's Pitch - Einstein Auditorium
(Panel added soon)
Apply until May 12th, 2024
19h00
Poster Presentation - Dinner Cocktail Reception at Exhibition Hall
20h30
Announcement of « BEST POSTER » by Biothérapie Innovation Occitanie
21h00
End of DAY 1
8h00
Welcome coffee
8h30
Efficacity and safety from preclinical to FIH trials - Einstein Auditorium
Session I
Lionel Renaud
PK/PD and Systems Pharmacology modeler
Lyo-X, Switzerland
Laurence del Frari
Pharmacokineticist, Modeling & Simulation
Pierre Fabre, France
Pierre Launay
Co-founder & COO
Inatherys, France
Non-oncology diseases/next generation of immunotherapies - Barthez Auditorium
Ole Søgaard
Professor
Institut for Klinisk Medicin, Aarhus University, Denmark
Carole Seguin-Devaux
Head of Research Unit
Luxemburg Institut of Health, Luxemburg
Mireia Pelegrin
DR-CNRS, Head of Antibodies, Immunomodulation and Immunotherapy group
IRMB-INSERM U1183-CHU Saint Eloi, France
10h00
Coffee Break at Exhibition Hall
10h30
Efficacity and safety from preclinical to FIH trials - Einstein Auditorium
Session II
Antoine Deslandes
Global Head of Pharmacokinetics for Devices & Biotherapeutics
SANOFI, France
Alex Phipps
Executive Director. Head of Clinical Pharmacology and Quantitative Pharmacology (CPQP) - Oncology
AstraZeneca, UK
AI and Machine Learning for Antibody discovery and Optimization - Barthez Auditorium
Pietro Sormanni
Group Leader, Royal Society Univ. Research Fellow
University of Cambridge, UK
Andrew Phillips
Head of Biologics AI Platform
SANOFI, UK
Thomas Bourquard
CSO and co-founder
MabSilico, France
12h10
Lunch at Exhibition Hall
14h00
Advancing new Antibodies approaches into the Clinic - Einstein Auditorium
Nicolas Poirier
CEO
Ose Immunotherapeutics, France
Vincent Muczynski
Director of Biology
NovalGen Ltd
Research Fellow
University College London - Cancer Institut, UK
Innovative Approaches to overcome Bioprocessing Challenges - Barthez Auditorium
Benoit Mothes
Head of Purification Process Development
SANOFI, France
David Balbuena
Director of Business Development
LFB Biomanufacturing, France
15h40
Closing Keynote - Einstein Auditorium
Luca Varani
Structural Biology Group Leader
Institute for Research in Biomedicine, Switzerland
16h10
Announcement of AIS2025
16h30
End of Congress
Organization contact
Ana Antunes
17 rue Crépet
69007 Lyon
+33 (0)6 26 33 63 21
ana-sofia.antunes@mabdesign.fr